Related Experiment Video
Updated: Feb 1, 2026

Porcine As a Training Module for Head and Neck Microvascular Reconstruction
Published on: September 29, 2018
Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study.
Yoh-Ichiro Iwasa1, Kentaro Hori2, Yoh Yokota2
1Department of Otorhinolaryngology-Head and Neck Surgery, Shinshu University School of Medicine, Matsumoto, Japan iwasa@shinshu-u.ac.jp.
Prior neck dissection (ND) in head and neck cancer (HNC) patients receiving immune checkpoint inhibitors (ICIs) was linked to poorer survival in locoregional disease but not distant metastasis. This suggests ND may impair T-cell priming, reducing ICI effectiveness.
Area of Science:
- Oncology
- Immunology
- Surgical Oncology
Background:
- T-cell priming in tumor-draining lymph nodes (TDLNs) is crucial for immune checkpoint inhibitor (ICI) efficacy.
- Neck dissection (ND) in head and neck cancer (HNC) may remove TDLNs, potentially impacting ICI outcomes.
- The clinical relevance of prior ND on subsequent ICI treatment in HNC requires investigation.
Purpose of the Study:
- To determine if prior ND affects treatment outcomes in patients with recurrent or metastatic HNC treated with nivolumab.
- To compare ICI efficacy in HNC patients with and without a history of ND.
Main Methods:
- Retrospective analysis of 54 HNC patients treated with nivolumab.
- Stratification into locoregional disease (LRD) and distant metastasis (DM) cohorts.
- Comparison of outcomes (progression-free survival, overall survival) between patients with and without prior ND within each cohort.
Main Results:
- In the LRD cohort, patients without prior ND had longer median overall survival (18.8 months) compared to those with prior ND (9.8 months; p=0.044).
- Progression-free survival showed a similar trend, favoring patients without prior ND (4.0 months vs. 2.3 months; p=0.089).
- Outcomes in the DM cohort were not significantly affected by prior ND.
Conclusions:
- Prior ND is associated with inferior survival outcomes in HNC patients with locoregional disease treated with nivolumab.
- The findings suggest that ND may reduce ICI efficacy by impairing TDLN function.
- Further research is warranted to explore the impact of surgical interventions on immunotherapy response in HNC.
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Muscles of the Anterior Neck
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Self-Efficacy

